Follow the 종근당바이오 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 종근당바이오 has recorded 2 insider filings. The latest transaction was reported on 25 February 2026 (Other). Among the most active insiders: 종근당바이오. Every trade is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
종근당바이오 is a South Korean company specializing in the health and pharmaceutical sector. It is listed on the XKRX stock exchange.